Skip to main content

Harvard Bioscience

(HBIO) - Get Harvard Bioscience Inc. Report

has completed its purchase of a group of microplate-reader and washer-product assets from Anthos Labtec Instruments, a unit of

Beckman Coulter


Scroll to Continue

TheStreet Recommends


Financial terms of the transaction weren't disclosed.

Harvard Bioscience, a developer of scientific instruments, said Wednesday that it expects the addition of the product lines to add roughly $2 million to $3 million in annualized revenue and to increase its earnings per share.

The company's stock was trading at $4.15, up 6 cents.

This story was created through a joint venture between and IRIS.